American Healthcare REIT Inc. (AHR) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
American Healthcare REIT Inc. (AHR) receives a Roarable Rating of D+ (Sell) and flashes a Red SELL / AVOID warning (67/100 RQD Confidence). Our SEC filing scanner spotted paper earnings outpacing real operating cash flow (+152.8% (NI vs OCF)) while unpaid customer invoices grew—a classic sign to step aside until cash flow catches up.
How AHR Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $2.09B | 14.4% | 19.8% | $70.8M | $200.2M | 7.9% |
| FY 2024 | $1.88B | 12.2% | 19.3% | -$35.6M | $91.3M | 9.1% |
| FY 2023 | $1.67B | 44% | 18.4% | -$76.9M | $23.4M | 5.9% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring AHR)
- ✓Live walkthrough of AHR's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
AHR Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +11.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on AHR today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for AHR. Explore sector supply chains on /butterfly.
AHR Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is American Healthcare REIT Inc. (AHR)?
In FY 2025 (10-K), AHR converted $2.1B of revenue into a 14.4% gross margin, 14.4% operating margin, and $200.2M in free cash flow (9.6% FCF margin).